Search

Author/Creator Cafardi, John

2. Chronic Liver Disease and COVID‐19: Alcohol Use Disorder/Alcohol‐Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis. Issue 5 (21st May 2020)

Authors:
Kushner, Tatyana; Cafardi, John
Other Names:
Ward John guestEditor.; Fix Oren guestEditor.
Journal:
Clinical liver disease
Issue:
Volume 15:Issue 5(2020)
Page Start:
195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS‐CoV‐2 neutralizing monoclonal antibody ABBV‐47D11 in patients with COVID‐19. Issue 1 (20th December 2022)

Authors:
Shebley, Mohamad; Wang, Stanley; Ali, Izna; Krishnan, Preethi; Tripathi, Rakesh; Reardon, Joseph M.; Cafardi, John; Rahav, Galia; Caraco, Yoseph; Slim, Jihad; Al Akhrass, Fadi; Yu, Mengjia; Hu, Yiran; Ferreira, Rosa De Abreu; Alami, Negar N.
Journal:
Pharmacology research & perspectives
Issue:
Volume 11:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Use of HCV Ab+/NAT− donors in HCV naïve renal transplant recipients to expand the kidney donor pool. Issue 7 (5th June 2019)

Authors:
Dao, Ann; Cuffy, Madison; Kaiser, Tiffany E.; Loethen, Ashley; Cafardi, John; Luckett, Keith; Rike, Adele Helen; Cardi, Michael; Alloway, Rita R.; Govil, Amit; Diwan, Tayyab; Sherman, Kenneth E.; Shah, Shimul A.; Woodle, Ervin Steve
Journal:
Clinical transplantation
Issue:
Volume 33:Issue 7(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗